Article Versions Notes

Fujimoto S, Endo M, Tonomura S, Tsuji F, Haraguchi H, Hasegawa K, Numao T, Izumi A, Tourtas T, Schlötzer-Schrehardt U, et al. Therapeutic Potential of Emricasan, a Pan-Caspase Inhibitor, in Reducing Cell Death and Extracellular Matrix Accumulation in Fuchs Endothelial Corneal Dystrophy. Cells. 2025; 14(7):498. https://doi.org/10.3390/cells14070498

Fujimoto, Sohya, Mako Endo, Shigehito Tonomura, Fuuga Tsuji, Hirotaka Haraguchi, Kanna Hasegawa, Taisuke Numao, Ayaka Izumi, Theofilos Tourtas, Ursula Schlötzer-Schrehardt, and et al. 2025. "Therapeutic Potential of Emricasan, a Pan-Caspase Inhibitor, in Reducing Cell Death and Extracellular Matrix Accumulation in Fuchs Endothelial Corneal Dystrophy" Cells 14, no. 7: 498. https://doi.org/10.3390/cells14070498

Fujimoto, S., Endo, M., Tonomura, S., Tsuji, F., Haraguchi, H., Hasegawa, K., Numao, T., Izumi, A., Tourtas, T., Schlötzer-Schrehardt, U., Kruse, F., Oyama, Y., Ikawa, M., Jun, A. S., Koizumi, N., & Okumura, N. (2025). Therapeutic Potential of Emricasan, a Pan-Caspase Inhibitor, in Reducing Cell Death and Extracellular Matrix Accumulation in Fuchs Endothelial Corneal Dystrophy. Cells, 14(7), 498. https://doi.org/10.3390/cells14070498